KR102600599B1 - Manufacturing method of hydrogel contact lens having reactive oxigen species scavenging ability using reactive polypehnol - Google Patents
Manufacturing method of hydrogel contact lens having reactive oxigen species scavenging ability using reactive polypehnol Download PDFInfo
- Publication number
- KR102600599B1 KR102600599B1 KR1020220025754A KR20220025754A KR102600599B1 KR 102600599 B1 KR102600599 B1 KR 102600599B1 KR 1020220025754 A KR1020220025754 A KR 1020220025754A KR 20220025754 A KR20220025754 A KR 20220025754A KR 102600599 B1 KR102600599 B1 KR 102600599B1
- Authority
- KR
- South Korea
- Prior art keywords
- reactive
- polyphenol
- contact lens
- active oxygen
- manufacturing
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 22
- 239000000017 hydrogel Substances 0.000 title claims abstract description 21
- 230000002000 scavenging effect Effects 0.000 title description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 47
- 239000001301 oxygen Substances 0.000 claims abstract description 46
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 46
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 46
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 42
- 239000000126 substance Substances 0.000 claims abstract description 18
- 238000000034 method Methods 0.000 claims abstract description 9
- 239000000178 monomer Substances 0.000 claims description 15
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 9
- 239000011259 mixed solution Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000012153 distilled water Substances 0.000 claims description 7
- 229960003638 dopamine Drugs 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- LZKGFGLOQNSMBS-UHFFFAOYSA-N 4,5,6-trichlorotriazine Chemical compound ClC1=NN=NC(Cl)=C1Cl LZKGFGLOQNSMBS-UHFFFAOYSA-N 0.000 claims description 4
- 239000003431 cross linking reagent Substances 0.000 claims description 4
- 239000003999 initiator Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 230000002194 synthesizing effect Effects 0.000 claims description 4
- 238000001953 recrystallisation Methods 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 238000003860 storage Methods 0.000 abstract description 3
- -1 oxygen radicals Chemical class 0.000 description 17
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical class [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 6
- 230000002292 Radical scavenging effect Effects 0.000 description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 6
- 125000000524 functional group Chemical group 0.000 description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 6
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 4
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 4
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 4
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 4
- 210000004087 cornea Anatomy 0.000 description 4
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 4
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 4
- QRIMLDXJAPZHJE-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(O)CO QRIMLDXJAPZHJE-UHFFFAOYSA-N 0.000 description 3
- IHDBZCJYSHDCKF-UHFFFAOYSA-N 4,6-dichlorotriazine Chemical compound ClC1=CC(Cl)=NN=N1 IHDBZCJYSHDCKF-UHFFFAOYSA-N 0.000 description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- XFCMNSHQOZQILR-UHFFFAOYSA-N 2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOC(=O)C(C)=C XFCMNSHQOZQILR-UHFFFAOYSA-N 0.000 description 2
- LTHJXDSHSVNJKG-UHFFFAOYSA-N 2-[2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCOCCOC(=O)C(C)=C LTHJXDSHSVNJKG-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 208000030533 eye disease Diseases 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- SPSSDDOTEZKOOV-UHFFFAOYSA-N 2,3-dichloroquinoxaline Chemical compound C1=CC=C2N=C(Cl)C(Cl)=NC2=C1 SPSSDDOTEZKOOV-UHFFFAOYSA-N 0.000 description 1
- GIKMWFAAEIACRF-UHFFFAOYSA-N 2,4,5-trichloropyrimidine Chemical compound ClC1=NC=C(Cl)C(Cl)=N1 GIKMWFAAEIACRF-UHFFFAOYSA-N 0.000 description 1
- HWSSEYVMGDIFMH-UHFFFAOYSA-N 2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCOC(=O)C(C)=C HWSSEYVMGDIFMH-UHFFFAOYSA-N 0.000 description 1
- WUGOQZFPNUYUOO-UHFFFAOYSA-N 2-trimethylsilyloxyethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCO[Si](C)(C)C WUGOQZFPNUYUOO-UHFFFAOYSA-N 0.000 description 1
- SQEDDFHZOPHSML-UHFFFAOYSA-N 3-[bis[3-(2-methylprop-2-enoyloxy)propyl]silyl]propyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCC[SiH](CCCOC(=O)C(C)=C)CCCOC(=O)C(C)=C SQEDDFHZOPHSML-UHFFFAOYSA-N 0.000 description 1
- BESKSSIEODQWBP-UHFFFAOYSA-N 3-tris(trimethylsilyloxy)silylpropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCC[Si](O[Si](C)(C)C)(O[Si](C)(C)C)O[Si](C)(C)C BESKSSIEODQWBP-UHFFFAOYSA-N 0.000 description 1
- YPIPEOPDBFEXKV-UHFFFAOYSA-N 4-chloro-5-fluorotriazine Chemical compound FC1=CN=NN=C1Cl YPIPEOPDBFEXKV-UHFFFAOYSA-N 0.000 description 1
- ORLGPUVJERIKLW-UHFFFAOYSA-N 5-chlorotriazine Chemical compound ClC1=CN=NN=C1 ORLGPUVJERIKLW-UHFFFAOYSA-N 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- CTENFNNZBMHDDG-UHFFFAOYSA-N Dopamine hydrochloride Chemical compound Cl.NCCC1=CC=C(O)C(O)=C1 CTENFNNZBMHDDG-UHFFFAOYSA-N 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- TVZBIANUIXSDRZ-UHFFFAOYSA-N [3-[bis(trimethylsilyloxy)methylsilyl]-2-(3-hydroxypropoxy)propyl] 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(C[SiH2]C(O[Si](C)(C)C)O[Si](C)(C)C)OCCCO TVZBIANUIXSDRZ-UHFFFAOYSA-N 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 description 1
- 229960001149 dopamine hydrochloride Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229940088644 n,n-dimethylacrylamide Drugs 0.000 description 1
- YLGYACDQVQQZSW-UHFFFAOYSA-N n,n-dimethylprop-2-enamide Chemical compound CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- AUXUGHDHDUZKFQ-UHFFFAOYSA-N trimethyl-[propyl-bis(trimethylsilyl)silyl]silane Chemical compound CCC[Si]([Si](C)(C)C)([Si](C)(C)C)[Si](C)(C)C AUXUGHDHDUZKFQ-UHFFFAOYSA-N 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
- B29D11/00—Producing optical elements, e.g. lenses or prisms
- B29D11/00009—Production of simple or compound lenses
- B29D11/00038—Production of contact lenses
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C71/00—After-treatment of articles without altering their shape; Apparatus therefor
- B29C71/0009—After-treatment of articles without altering their shape; Apparatus therefor using liquids, e.g. solvents, swelling agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
- B29D11/00—Producing optical elements, e.g. lenses or prisms
- B29D11/00009—Production of simple or compound lenses
- B29D11/0048—Moulds for lenses
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
- B29D11/00—Producing optical elements, e.g. lenses or prisms
- B29D11/00865—Applying coatings; tinting; colouring
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
- C08J7/04—Coating
- C08J7/06—Coating with compositions not containing macromolecular substances
- C08J7/065—Low-molecular-weight organic substances, e.g. absorption of additives in the surface of the article
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C71/00—After-treatment of articles without altering their shape; Apparatus therefor
- B29C71/0009—After-treatment of articles without altering their shape; Apparatus therefor using liquids, e.g. solvents, swelling agents
- B29C2071/0027—Removing undesirable residual components, e.g. solvents, unreacted monomers
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Manufacturing & Machinery (AREA)
- Ophthalmology & Optometry (AREA)
- Mechanical Engineering (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Eyeglasses (AREA)
Abstract
본 발명은 반응성 폴리페놀을 이용한 활성산소제거 기능을 갖는 콘택트렌즈의 제조방법에 관한 것으로서, 다량의 폴리페놀이 화학적 결합으로 렌즈에 고정되어 보관 및 착용시에는 폴리페놀이 방출되지 않고 활성산소제거 유효성이 우수한 하이드로겔 콘택트렌의 제조방법에 관한 것이다.The present invention relates to a method of manufacturing a contact lens with an active oxygen removal function using reactive polyphenol, in which a large amount of polyphenol is fixed to the lens through a chemical bond, so that polyphenol is not released during storage and wearing, and active oxygen removal effectiveness is achieved. This relates to a method for manufacturing excellent hydrogel contact lenses.
Description
본 발명은 반응성 폴리페놀을 이용한 활성산소제거 기능성 하이드로겔 콘택트렌즈의 제조방법에 관한 것으로서, 다량의 폴리페놀이 화학적 결합으로 렌즈에 결합되어 보관 및 착용 시에는 폴리페놀이 방출되지 않고 활성산소제거 유효성이 우수한 하이드로겔 콘택트렌즈의 제조방법에 관한 것이다.The present invention relates to a method of manufacturing hydrogel contact lenses with active oxygen removal functionality using reactive polyphenols. A large amount of polyphenol is bound to the lens through a chemical bond, so that polyphenols are not released during storage and wearing, and the effectiveness of active oxygen removal is achieved. This relates to a method of manufacturing excellent hydrogel contact lenses.
콘택트렌즈(Contact lens)는 안경에 비하여 시야가 넓고 안경의 착용에서 오는 미용상의 불이익을 피할 수 있는 장점 때문에 널리 사용되어 오고 있으며, 현재 콘택트렌즈는 시력교정, 치료용 외에도 미용용 등으로 그 영역이 확대되면서 시장이 지속적으로 성장하고 있다.Contact lenses have been widely used because they have a wider field of view than glasses and have the advantage of avoiding the cosmetic disadvantages of wearing glasses. Currently, contact lenses are used for cosmetic purposes in addition to vision correction and treatment. The market continues to grow as it expands.
이러한 콘택트렌즈는 안구에 직접 접촉함으로써, 눈의 안전과 효능을 유지하는 동시에 콘택트렌즈의 투명성과 표면 습윤성을 유지해야 하고, 안구의 각막을 향해 산소를 잘 투과하여야 한다. 즉, 콘택트렌즈는 안구 및 각막을 보호함과 동시에 눈물 층의 흐름이 원활해야 하고, 눈꺼풀과 눈 표면과의 과다한 마찰도 피해야 하는 임상학적인 측면도 고려하여 설계되어야 하며, 기계적 강도(tensile strength), 생체적합성(biocompatibility), 무독성(non toxicity), 광학적 투명도(optical transparent), 굴절율(refractive index), 표면친수성(surface wetability), 각막에 적합한 함수율(water content), 팽윤비(welling rate), 산소투과성(oxygen permeability) 등의 조건들을 충족시켜야 한다.These contact lenses must maintain eye safety and efficacy by directly contacting the eye, while maintaining transparency and surface wettability of the contact lens, and must be able to transmit oxygen well toward the cornea of the eye. In other words, contact lenses must be designed with clinical aspects in mind, such as protecting the eye and cornea while ensuring smooth flow of the tear layer, avoiding excessive friction between the eyelid and the eye surface, and maintaining mechanical strength (tensile strength) and biological properties. Biocompatibility, non-toxicity, optical transparency, refractive index, surface wetability, water content suitable for the cornea, swelling rate, oxygen permeability ( Conditions such as oxygen permeability must be met.
상기와 같은 콘택트렌즈는 재료에 따라 크게 하드(hard) 콘택트렌즈와 소프트(soft) 콘택트렌즈로 나눌 수 있으며, 기능에 따라 시력교정용, 치료용, 미용 콘택트렌즈 등으로 분류되며, 최근에는 하이드로겔 소프트 콘택트렌즈가 대부분 현대인들의 시력교정 및 치료 등의 목적으로 사용되고 있다.Contact lenses as described above can be broadly divided into hard contact lenses and soft contact lenses depending on the material, and are classified into vision correction, therapeutic, and cosmetic contact lenses according to function, and recently, hydrogel contact lenses. Soft contact lenses are mostly used by modern people for vision correction and treatment purposes.
한편, 누액 및 안구 내 활성산소는 단백질의 산화 손상을 일으키고, 백내장과 같은 치명적인 안구 질환을 야기시키며, 수정체와 망막의 노화를 가속화시킨다. 따라서, 활성산소제거 기능의 렌즈 착용은 각종 안구노화 및 활성산소 유발 안질환의 발병 위험을 줄여줄 수 있다. 활성산소제거 물질의 경구투여 보다, 콘택트렌즈를 통한 처방이 각막 및 안구 내에서 효율적으로 작용하므로, 활성산소제거 기능을 갖는 하이드로겔 렌즈가 개발되어지면, 안구건강에 도움을 줄 것이다.Meanwhile, active oxygen in tear fluid and the eye causes oxidative damage to proteins, causes fatal eye diseases such as cataracts, and accelerates the aging of the lens and retina. Therefore, wearing lenses with an active oxygen removal function can reduce the risk of developing various eye aging and oxygen-induced eye diseases. Since prescription through contact lenses acts more efficiently within the cornea and eye than oral administration of active oxygen scavenging substances, the development of hydrogel lenses with active oxygen scavenging functions will help eye health.
폴리페놀 유도체는 자체가 산화되면서 활성산소를 제거하는 기능을 가지고 있다. 폴리페놀이 콘택트렌즈에 물리적으로 결합되어 있다면 활성산소제거 효과를 유지할 수 있도록 폴리페놀을 자주 투여해야 하는 불편함이 있고, 유효한 활성산소 제거 농도의 유지시간이 짧다는 점의 문제점이 있다. Polyphenol derivatives have the function of removing active oxygen by oxidizing themselves. If the polyphenol is physically bound to the contact lens, there is the inconvenience of having to administer the polyphenol frequently to maintain the effect of removing oxygen radicals, and the maintenance time of the effective oxygen radical removal concentration is short.
활성산소제거 기능을 갖는 콘택트렌즈 개발은 해외 다국적 업체들의 관심 분야로, 최근 보존액을 이용한 혼합 방법으로 관련 시장을 개척하고 있다. 이들 기업의 보유 기술의 경우, 착용 후, 몇 시간 내 활성산소제거 물질이 방출되는 치명적인 단점을 보이고 있다.The development of contact lenses with an active oxygen removal function is an area of interest for overseas multinational companies, and they are recently pioneering the related market using a mixing method using a preservative solution. The technologies owned by these companies have the fatal disadvantage of releasing oxygen radicals within a few hours of wearing them.
따라서 하이드로겔 콘택트렌즈에 반응성 폴리페놀 소재를 화학적으로 결합시킴으로써 이러한 활성산소제거 기능을 효과적으로 유지하는 콘택트렌즈를 개발할 수 있을 것으로 기대된다.Therefore, it is expected that contact lenses that effectively maintain this active oxygen removal function can be developed by chemically combining reactive polyphenol materials with hydrogel contact lenses.
본 발명은 상기의 문제점을 개선하고자 창출된 것으로서, 보관 및 착용시에는 활성산소제거 기능의 폴리페놀이 방출되지 않고자 반응성 폴리페놀을 합성하고 이를 화학적 공유 결합으로 렌즈에 고정하여 활성산소제거 기능의 하이드로겔 콘택트렌즈 및 그 제조방법을 제공하는 데 그 목적이 있다.The present invention was created to improve the above problems. In order to prevent the polyphenol with the active oxygen removal function from being released when stored and worn, reactive polyphenol is synthesized and fixed to the lens with a chemical covalent bond to provide the active oxygen removal function. The purpose is to provide hydrogel contact lenses and their manufacturing method.
상기의 목적을 달성하기 위한 본 발명의 활성산소제거 기능을 갖는 콘택트렌즈의 제조방법은 하이드로겔 형성용 단량체에 개시제 및 가교제를 혼합하여 혼합액을 수득하고, 상기 혼합액을 몰드에 주입하여 중합시키는 콘택트렌즈 제조단계, 반응성 폴리페놀을 합성하는 단계, 상기 반응성 폴리페놀을 상기 콘택트렌즈에 결합시켜 활성산소제거 기능을 부여하는 단계를 포함하는 것을 특징으로 한다.In order to achieve the above object, the method of manufacturing a contact lens having an active oxygen removal function of the present invention is to obtain a mixed solution by mixing a monomer for forming a hydrogel with an initiator and a crosslinking agent, and injecting the mixed solution into a mold to polymerize the contact lens. It is characterized by comprising a manufacturing step, a step of synthesizing a reactive polyphenol, and a step of binding the reactive polyphenol to the contact lens to provide an active oxygen removal function.
이때, 상기 반응성 폴리페놀 합성 단계는, a) 폴리페놀 유도체인 도파민과 트리클로로트리아진(trichlorotriazine)을 반응시키는 단계, b) 과량의 미반응 물질을 재결정 과정으로 제거하고 반응성 폴리페놀을 얻는 단계를 포함할 수 있다.At this time, the reactive polyphenol synthesis step includes the steps of a) reacting dopamine, a polyphenol derivative, with trichlorotriazine, and b) removing excess unreacted material through a recrystallization process and obtaining reactive polyphenol. can do.
또한, 상기 활성산소제거 기능을 콘택트렌즈에 부여하는 단계는, a) 상기 콘택트렌즈를 증류수에 넣고 알칼리 물질을 첨가하여 염기성으로 조절한 후 교반하는 단계, b) 상기 반응성 폴리페놀을 첨가하여 콘택트렌즈에 화학적 고정하는 단계. c) 미반응 물질을 제거하는 세척 단계를 포함할 수 있다.In addition, the step of imparting the active oxygen removal function to the contact lens includes a) adding the contact lens to distilled water, adding an alkaline substance to adjust the basicity, and then stirring, b) adding the reactive polyphenol to the contact lens. Chemical fixation step. c) may include a washing step to remove unreacted substances.
본 발명에 따른 렌즈의 제조방법에서는 반응성 폴리페놀을 합성하고, 이를 콘택트렌즈에 화학적으로 고정하여 활성산소제거 기능을 갖도록 하는 것이므로, 렌즈의 유통, 보관, 착용시에는 폴리페놀이 방출되지 않으며, 착용시 장시간 동안 적절한 활성산소제거 효능을 가질 수 있도록 하는 효과를 나타낸다.In the manufacturing method of the lens according to the present invention, reactive polyphenol is synthesized and chemically fixed to the contact lens to have an active oxygen removal function. Therefore, polyphenol is not released during distribution, storage, and wearing of the lens, and It shows the effect of having appropriate active oxygen removal effect for a long period of time.
또한, 본 발명의 제조공정에 사용되는 반응성 폴리페놀은 기존의 콘택트렌즈 제조 공정에 그대로 적용할 수 있어 상업적으로 유용하게 활용될 수 있다.In addition, the reactive polyphenol used in the manufacturing process of the present invention can be directly applied to the existing contact lens manufacturing process and can be utilized commercially.
도 1은 본 발명의 활성산소제거 기능의 하이드로겔 콘택트렌즈의 제조방법을 나타낸 모식도이다.Figure 1 is a schematic diagram showing a method of manufacturing a hydrogel contact lens with an active oxygen removal function of the present invention.
이하, 본 발명의 바람직한 실시예에 따른 반응성 폴리페놀을 이용한 활성산소제거 기능의 하이드로겔 콘택트렌즈와 이의 제조방법에 대하여 설명한다.Hereinafter, a hydrogel contact lens with an active oxygen removal function using reactive polyphenol according to a preferred embodiment of the present invention and a method for manufacturing the same will be described.
본 발명의 활성산소제거 기능을 갖는 콘택트렌즈의 제조방법은 도 1에 도시된 것과 같은 과정을 통해 수행될 수 있다. 즉, 하이드로겔 형성용 단량체에 개시제 및 가교제를 혼합하여 혼합액을 수득하고, 상기 혼합액을 몰드에 주입하여 중합시키는 콘택트렌즈 제조단계, 반응성 폴리페놀을 합성하는 단계, 상기 반응성 폴리페놀을 상기 콘택트렌즈에 결합시켜 활성산소제거 기능을 부여하는 단계를 포함하는 것을 특징으로 한다.The method of manufacturing a contact lens having an active oxygen removal function of the present invention can be performed through the same process as shown in FIG. 1. That is, a contact lens manufacturing step of mixing a monomer for hydrogel formation with an initiator and a crosslinking agent to obtain a mixed solution, injecting the mixed solution into a mold to polymerize it, synthesizing a reactive polyphenol, and adding the reactive polyphenol to the contact lens. It is characterized by comprising the step of imparting an active oxygen removal function by binding.
상기 콘택트렌즈는 히드록시메타크릴레이트(HEMA, hydroxyethyl methacrylate) 58 내지 98중량%, 실리콘 단량체 20내지 40중량%, 친수성을 위한 N-비닐피롤리돈(N-vinyl-pyrrolidone) 0.1 내지 40중량%, 가교제로서 에틸렌글리콜디메타크릴레이트(ethylene glycol dimethacrylate) 0.1 내지 2.0중량%, 개시제로서 아조비시소부티로니트릴(AIBN, azobisisobutyronitrile) 0.01 내지 0.5중량%를 함유하는 단량체 용액을 형성한 후 이를 중합시켜 제조할 수 있다.The contact lenses contain 58 to 98% by weight of hydroxyethyl methacrylate (HEMA), 20 to 40% by weight of silicone monomer, and 0.1 to 40% by weight of N-vinyl-pyrrolidone for hydrophilicity. , forming a monomer solution containing 0.1 to 2.0% by weight of ethylene glycol dimethacrylate as a crosslinker and 0.01 to 0.5% by weight of azobisisobutyronitrile (AIBN) as an initiator, and then polymerizing it. It can be manufactured.
상기의 단량체 용액으로 중합 형성된 렌즈본체는 수화되어 하이드로겔 구조를 갖는다. 하이드로겔은 다량의 수분을 함유할 수 있는 삼차원의 친수성 고분자 망상구조를 가진 물질이다. 하이드로겔은 단일중합체 또는 공중합체로 이루어지며, 유동성이 거의 없이 구조적으로 안정한 삼차원 네트워크 구조를 형성한다. The lens body polymerized with the above monomer solution is hydrated and has a hydrogel structure. Hydrogel is a material with a three-dimensional hydrophilic polymer network structure that can contain a large amount of moisture. Hydrogels are made of homopolymers or copolymers and form a structurally stable three-dimensional network structure with little fluidity.
본 발명에서 하이드로겔 형성용 단량체로 친수성 아크릴 단량체를 이용할 수 있다. 친수성 아크릴 단량체(monomer)는 하이드록시기가 1 내지 3개 치환된 C1-C15 하이드록시알킬 메타크릴레이트, 하이드록시기가 1 내지 3개 치환된 C1-C15 하이드록시알킬 아크릴레이트, 아크릴아미드(acrylamide), 비닐피롤리돈(vinyl pyrrolidone), 글리세롤 메타크릴레이트(glycerol methacrylate), 아크릴산 및 메타크릴산으로부터 선택된 어느 하나일 수 있다. In the present invention, a hydrophilic acrylic monomer can be used as a monomer for forming hydrogel. Hydrophilic acrylic monomers include C1-C15 hydroxyalkyl methacrylate with 1 to 3 hydroxy groups substituted, C1-C15 hydroxyalkyl acrylate with 1 to 3 hydroxy groups substituted, acrylamide, It may be any one selected from vinyl pyrrolidone, glycerol methacrylate, acrylic acid, and methacrylic acid.
친수성 아크릴 단량체의 구체적인 예로서, 하이드록시에틸메타크릴레이트(2-hydroxyethyl methacrylate, HEMA), N,N-디메틸아크릴아미드(N,N-dimethyl acrylamide, DMA), N-비닐피롤리돈(N-vinylpyrrolidone, NVP), 글리세롤모노메타크릴레이트(glycerol monomethacrylate, GMMA), 메타크릴산(methacrylic acid, MA) 등을 들 수 있다. Specific examples of hydrophilic acrylic monomers include 2-hydroxyethyl methacrylate (HEMA), N,N-dimethyl acrylamide (DMA), and N-vinylpyrrolidone (N- Examples include vinylpyrrolidone (NVP), glycerol monomethacrylate (GMMA), and methacrylic acid (MA).
또한, 실리콘 단량체의 예로서, 트리스(3-메타크릴옥시프로필)실란, 2-(트리메틸실릴옥시)에틸 메타크릴레이트, 3-트리스(트리메틸실릴옥시)실릴프로필 메타크릴레이트, 3-메타크릴옥시프로필 트리스(트리메틸실릴)실란(MPTS), 3-메타크릴옥시-2-(하이드록시프로필옥시)프로필비스(트리메틸실록시)메틸실란 및 4-메타크릴옥시부틸 터미네이티드 폴리디메틸실록산 등으로부터 선택된 어느 하나일 수 있다.Additionally, examples of silicone monomers include tris(3-methacryloxypropyl)silane, 2-(trimethylsilyloxy)ethyl methacrylate, 3-tris(trimethylsilyloxy)silylpropyl methacrylate, and 3-methacryloxy. selected from propyl tris(trimethylsilyl)silane (MPTS), 3-methacryloxy-2-(hydroxypropyloxy)propylbis(trimethylsiloxy)methylsilane, and 4-methacryloxybutyl terminated polydimethylsiloxane, etc. It could be any one.
또한, 가교제로 에틸렌글리콜 디메타크릴레이트(ethylene glycol dimethacrylate,EGDMA), 아크릴산(acrylic acid), 메타크릴산(methacrylic acid), 아크릴아미드(acrylamide), 메타크릴아미드(methacrylamide), 디에틸렌글리콜 디메타크릴레이트(diethylene glycol dimethacrylate), 트리에틸렌글리콜 디메타크릴레이트(triethylene glycol dimethacrylate) 또는 테트라에틸렌글리콜 디메타크릴레이트(tetraethylene glycol dimethacrylate) 등을 이용할 수 있다. In addition, crosslinking agents include ethylene glycol dimethacrylate (EGDMA), acrylic acid, methacrylic acid, acrylamide, methacrylamide, and diethylene glycol dimetha. Crylate (diethylene glycol dimethacrylate), triethylene glycol dimethacrylate, or tetraethylene glycol dimethacrylate (tetraethylene glycol dimethacrylate) can be used.
상기 활성산소제거 기능 소재에 하이드록시기(-OH)와 화학적 공유결합이 가능한 반응성 작용기의 도입이 바람직하다. 반응성 작용기로 디클로로트리아진(dichlorotriazine), 모노클로로트리아진(monochlorotriazine), 트리클로로피리미딘(trichloropyrimidine), 디클로로퀴녹살린(dichloroquinoxaline), 모노플루오로클로로트리아진(monofluorochlorotriazine), 디플루오로클로로피리미딘(difluorochloropyrimidine) 등을 들 수 있다. 또한, 반응성 작용기로 vinyl sulfone과 vinyl amide 등을 들 수 있다.It is desirable to introduce a reactive functional group capable of forming a chemical covalent bond with a hydroxyl group (-OH) in the active oxygen removal functional material. Reactive functional groups include dichlorotriazine, monochlorotriazine, trichloropyrimidine, dichloroquinoxaline, monofluorochlorotriazine, and difluorochloropyrimidine ( difluorochloropyrimidine) and the like. Additionally, reactive functional groups include vinyl sulfone and vinyl amide.
상술한 반응성 작용기를 갖는 활성산소제거 소재로 폴리페놀 유도체를 들 수 있다. 구체적으로 폴리페놀 유도체로 카테킨(catechin), 레스베라트롤(resveratrol), 퀘르세틴(quercetin), 안토시아닌(anthocyanin), 프로안토시아닌(proanthocyanin), 플라보노이드(flavonoid), 이소플라본(isoflavone), 플라보노이드(flavonoid), 타닌(tannin), 리그린(lignin), 도파민(dopamine) 등을 들 수 있다.Polyphenol derivatives may be used as active oxygen removal materials having the above-mentioned reactive functional groups. Specifically, polyphenol derivatives include catechin, resveratrol, quercetin, anthocyanin, proanthocyanin, flavonoid, isoflavone, flavonoid, and tannin ( Examples include tannin, lignin, and dopamine.
본 발명의 활성산소제거 기능을 갖는 콘택트렌즈는 하이드로겔 콘택트렌즈를 제조한 후에 반응성 폴리페놀 유도체를 화학적 결합으로 콘택트렌즈에 고정시키는 공정을 통해 제조되는 것인데, 전술한 바와 같이, 상기 하이드로겔 형성용 단량체로는 아크릴 단량체 또는 실리콘 단량체를 사용할 수 있다. The contact lens having an active oxygen removal function of the present invention is manufactured through a process of fixing a reactive polyphenol derivative to the contact lens through a chemical bond after manufacturing the hydrogel contact lens. As described above, for forming the hydrogel As the monomer, an acrylic monomer or a silicone monomer can be used.
상기 반응성 폴리페놀은 반응성 작용기인 디클로로트리아진(dichlorotriazine)을 포함하는 것으로서, 염기조건하에서 하이드록시기(-OH)와 공유결합이 가능하게 된다. 또한, 상기 반응성 폴리페놀은 콘택트렌즈가 함유하고 있는 하이드록시기(-OH) 작용기와 공유결합을 형성한다. The reactive polyphenol contains dichlorotriazine, a reactive functional group, and can form a covalent bond with a hydroxy group (-OH) under basic conditions. Additionally, the reactive polyphenol forms a covalent bond with the hydroxyl (-OH) functional group contained in the contact lens.
일 실시예에서 상기 반응성 폴리페놀로 폴리페놀 유도체 중에서 하기의 화학식으로 표현되는 화합물인 도파민을 이용하였다.In one example, dopamine, a compound represented by the following chemical formula among polyphenol derivatives, was used as the reactive polyphenol.
[화학식][Chemical formula]
상기 반응성 폴리페놀은 하기 반응식을 통해 합성될 수 있다.The reactive polyphenol can be synthesized through the following reaction formula.
[반응식][Reaction formula]
구체적으로 상기 반응성 폴리페놀은 a) 폴리페놀 유도체인 도파민과 트리클로로트리아진(trichlorotriazine)을 반응시키는 단계, b) 과량의 미반응 물질을 재결정 과정으로 제거하고 반응성 폴리페놀을 얻는 단계를 포함하여 합성될 수 있다.Specifically, the reactive polyphenol is synthesized including the steps of a) reacting dopamine, a polyphenol derivative, with trichlorotriazine, b) removing excess unreacted material through a recrystallization process and obtaining reactive polyphenol. You can.
상기와 같은 반응성 폴리페놀은 활성산소제거 기능을 나타내는 폴리페놀 부분과 하이드록시기와 반응할 수 있는 디클로로트리아진기가 결합된 구조이므로 본 발명에서 목적하는 하이드로겔 콘택트렌즈에 활성산소제거 기능을 부여할 수 있게 된다.The above-mentioned reactive polyphenol has a structure that combines a polyphenol portion that exhibits an active oxygen removal function and a dichlorotriazine group that can react with a hydroxy group, so it can impart an active oxygen removal function to the hydrogel contact lens of interest in the present invention. There will be.
또한, 상기 활성산소제거 기능을 콘택트렌즈에 부여하는 단계는 a) 상기 콘택트렌즈를 증류수에 넣고 알칼리 물질을 첨가하여 염기성으로 조절한 후 교반하는 단계, b) 상기 반응성 폴리페놀을 첨가하여 콘택트렌즈에 화학적 고정하는 단계, c) 미반응 물질을 제거하는 세척 단계를 포함할 수 있다.In addition, the step of imparting the active oxygen removal function to the contact lens is a) putting the contact lens in distilled water, adding an alkaline substance to adjust the basicity, and then stirring, b) adding the reactive polyphenol to the contact lens. It may include a chemical fixation step, c) a washing step to remove unreacted substances.
이하, 본 발명을 하기 실험예를 통하여 구체적으로 설명한다. 이는 본 발명을 보다 상세하게 설명하기 위한 것으로, 본 발명의 권리 범위를 하기의 실험 예로 한정하는 것은 아니다.Hereinafter, the present invention will be described in detail through the following experimental examples. This is for explaining the present invention in more detail, and does not limit the scope of the present invention to the following experimental examples.
<반응성 폴리페놀(dichlorotriazine-dopamine)의 합성><Synthesis of reactive polyphenol (dichlorotriazine-dopamine)>
도파민 하이드로클로라이드(Dopamine hydrochloride)(1.00g, 6.53mmol), 트리에틸아민(triethylamine)(1.32g, 13.1mmol), 트리클로로트리아진(trichlorotriazine)(8.43g, 45.7mmol)을 증류수 100㎖에 녹이고, 상온에서 12시간 동안 교반하여 반응시켰다. 메틸렌 클로라이드(Methylene chloride) 200㎖로 추출하고, 헥산을 첨가하여 침전되는 반응성 폴리페놀인 4-(2-((4,6-dichloro-1,3,5-triazin-2-yl)amino)ethyl) benzene-1,2-diol 1.1g을 수득하였으며, 상기 화합물을 dichlorotriazine-dopamine으로 명명하였다.Dissolve dopamine hydrochloride (1.00g, 6.53mmol), triethylamine (1.32g, 13.1mmol), and trichlorotriazine (8.43g, 45.7mmol) in 100ml of distilled water and leave at room temperature. The reaction was stirred for 12 hours. 4-(2-((4,6-dichloro-1,3,5-triazin-2-yl)amino)ethyl, a reactive polyphenol, is extracted with 200 ml of methylene chloride and precipitated by adding hexane. ) 1.1g of benzene-1,2-diol was obtained, and the compound was named dichlorotriazine-dopamine.
<콘택트렌즈 제조><Contact lens manufacturing>
HEMA 단량체는 진공증류를 통해 중합방지제 및 불순물을 정제 후 사용하였다. EGDMA 0.04g, AIBN 0.04g를 9.92g의 HEMA 용액에 녹인 후 1시간 동안 상온에서 교반하여 혼합액을 얻는다. 혼합액을 콘택트렌즈 몰드에 주입하고, 120℃의 오븐에서 30분 중합하여 콘택트렌즈를 제조하였다. 몰드에서 콘택트렌즈를 제거한 후, 콘택트렌즈를 2일 동안 증류수에서 세척하여 반응하지 않은 물질들을 제거하였다. HEMA monomer was used after purification of polymerization inhibitors and impurities through vacuum distillation. Dissolve 0.04 g of EGDMA and 0.04 g of AIBN in 9.92 g of HEMA solution and stir at room temperature for 1 hour to obtain a mixed solution. The mixed solution was injected into a contact lens mold and polymerized in an oven at 120°C for 30 minutes to prepare contact lenses. After removing the contact lens from the mold, the contact lens was washed in distilled water for 2 days to remove unreacted substances.
<활성산소제거 기능성 콘택트렌즈 제조><Manufacture of active oxygen removal functional contact lenses>
콘택트렌즈를 증류수 50㎖에 넣고, NaOH 0.5M 용액으로 pH를 8로 조정한 뒤 3시간 동안 교반하였다. Dichlorotriazine-dopamine을 각 0, 0.1, 0.2M가 되도록 첨가하고 상온에서 12시간 동안 교반하였다. 콘택트렌즈를 2일 동안 증류수에서 세척하여 반응하지 않은 물질들을 제거하며, 처리한 dichlorotriazine-dopamine 농도에 따라 아래 표와 같이 Lens 1, 2, 3로 명명하였다.The contact lenses were placed in 50 ml of distilled water, the pH was adjusted to 8 with a 0.5 M NaOH solution, and the mixture was stirred for 3 hours. Dichlorotriazine-dopamine was added to 0, 0.1, and 0.2M respectively and stirred at room temperature for 12 hours. The contact lenses were washed in distilled water for 2 days to remove unreacted substances, and were named Lens 1, 2, and 3 according to the treated dichlorotriazine-dopamine concentration as shown in the table below.
<활성산소제거 기능 측정 시험><Active oxygen removal function measurement test>
활성산소제거 특성을 free radical 발생 시약인 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay방법을 통해 평가하였다. DPPH 시약은 홀전자인 라디칼을 가지고 있을 보라색이지만, DPPH의 라디칼을 제거하는 폴리페놀과 만나면 노란색을 띄며 라디칼소거기능의 특성을 확인시켜 준다. DPPH assay는 화합물의 라디칼소거기능을 판별해주며, 이는 라디칼을 가지고 있는 활성산소를 제거하는 항산화기능과 동일하게 인정되기 때문에, 항산화기능 평가에 사용되는 유용한 방법이다. The oxygen radical removal properties were evaluated using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay, a free radical generating reagent. The DPPH reagent is purple because it contains an unpaired radical, but when it comes in contact with polyphenol, which removes the radical of DPPH, it turns yellow, confirming the characteristics of the radical scavenging function. The DPPH assay determines the radical scavenging function of a compound, and is recognized as the same as the antioxidant function of removing free radicals containing radicals, so it is a useful method used to evaluate antioxidant function.
DPPH 용액의 라디칼 소거 정도를 UV-vis spectrophotometer를 이용해 측정하였다. DPPH 용액은 DPPH 0.0079 g을 100mL 에탄올에 넣어 제조하여 사용하였다(0.2 mM DPPH용액). 렌즈가 담긴 바이알에 제조된 DPPH 용액 2.7㎖를 첨가한 뒤, 상온에서 교반하면서 517㎚에서 흡광도 변화를 측정하여 아래식을 이용하여 라디칼소거율을 결정하였다.The degree of radical scavenging of the DPPH solution was measured using a UV-vis spectrophotometer. The DPPH solution was prepared by adding 0.0079 g of DPPH to 100 mL of ethanol (0.2 mM DPPH solution). After adding 2.7 ml of the prepared DPPH solution to the vial containing the lens, the change in absorbance was measured at 517 nm while stirring at room temperature, and the radical scavenging rate was determined using the formula below.
<활성산소제거 기능 측정 결과><Active oxygen removal function measurement results>
측정한 DPPH 라디칼소거율은 아래 표 2와 같다. 활성산소제거 기능의 dichlorotriazine-dopamine가 고정되지 않은 대조군 Lens 1의 경우, 대략 5%의 첨가된 DPPH 라디칼을 제거하였다. Dichlorotriazine-dopamine 0.1M이 처리된 Lens 2는 약 25%, 0.2M이 처리된 Lens 3는 약 53%의 높은 DPPH 라디칼 제거 기능을 보여주었다.The measured DPPH radical scavenging rate is shown in Table 2 below. In the case of control Lens 1, in which dichlorotriazine-dopamine with an active oxygen removal function was not immobilized, approximately 5% of the added DPPH radicals were removed. Lens 2 treated with 0.1M dichlorotriazine-dopamine showed a high DPPH radical removal function of about 25%, and Lens 3 treated with 0.2M showed a high DPPH radical removal function of about 53%.
이러한 결과로부터 본 발명의 제조방법에 의해 제조된 하이드로겔 콘택트렌즈는 활성산소제거 성능이 우수한 물성을 나타내는 것으로 파악되었다.From these results, it was determined that the hydrogel contact lens manufactured by the manufacturing method of the present invention exhibits excellent physical properties in terms of oxygen removal performance.
Claims (3)
반응성 폴리페놀을 합성하는 단계;
상기 반응성 폴리페놀을 상기 콘택트렌즈에 결합시켜 활성산소제거 기능을 부여하는 단계;
를 포함하며,
상기 반응성 폴리페놀을 합성하는 단계는,
a) 폴리페놀 유도체인 도파민과 트리클로로트리아진(trichlorotriazine)을 반응시키는 단계;
b) 과량의 미반응 물질을 재결정 과정으로 제거하고 반응성 폴리페놀을 얻는 단계;
를 포함하는 것을 특징으로 하는 활성산소제거 기능을 갖는 콘택트렌즈의 제조방법.
A contact lens manufacturing step of mixing a monomer for forming a hydrogel with an initiator and a crosslinking agent to obtain a mixed solution, and injecting the mixed solution into a mold to polymerize it;
synthesizing reactive polyphenols;
imparting an active oxygen removal function by binding the reactive polyphenol to the contact lens;
Includes,
The step of synthesizing the reactive polyphenol is,
a) reacting dopamine, a polyphenol derivative, with trichlorotriazine;
b) removing excess unreacted material through a recrystallization process and obtaining reactive polyphenol;
A method of manufacturing a contact lens having an active oxygen removal function, comprising:
상기 활성산소제거 기능을 콘택트렌즈에 부여하는 단계는,
a) 상기 콘택트렌즈를 증류수에 넣고 알칼리 물질을 첨가하여 염기성으로 조절한 후 교반하는 단계;
b) 상기 반응성 폴리페놀을 첨가하여 콘택트렌즈에 화학적 고정하는 단계;
c) 미반응 물질을 제거하는 세척 단계;
를 포함하는 것을 특징으로 하는 활성산소제거 기능을 갖는 콘택트렌즈의 제조방법.In claim 1,
The step of providing the active oxygen removal function to the contact lens is,
a) putting the contact lenses in distilled water, adding an alkaline substance to adjust basicity, and then stirring;
b) chemically fixing contact lenses by adding the reactive polyphenol;
c) a washing step to remove unreacted substances;
A method of manufacturing a contact lens having an active oxygen removal function, comprising:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220025754A KR102600599B1 (en) | 2022-02-28 | 2022-02-28 | Manufacturing method of hydrogel contact lens having reactive oxigen species scavenging ability using reactive polypehnol |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220025754A KR102600599B1 (en) | 2022-02-28 | 2022-02-28 | Manufacturing method of hydrogel contact lens having reactive oxigen species scavenging ability using reactive polypehnol |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20230128653A KR20230128653A (en) | 2023-09-05 |
KR102600599B1 true KR102600599B1 (en) | 2023-11-09 |
Family
ID=87973691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020220025754A KR102600599B1 (en) | 2022-02-28 | 2022-02-28 | Manufacturing method of hydrogel contact lens having reactive oxigen species scavenging ability using reactive polypehnol |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102600599B1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006136409A (en) | 2004-11-10 | 2006-06-01 | Hoya Corp | Method for manufacturing surface-treated intraocular lens and secondary cataract inhibiting intraocular lens |
US20180292677A1 (en) | 2017-04-10 | 2018-10-11 | Benq Materials Corporation | Ophthalmic lens and method for manufacturing the same |
KR101963513B1 (en) | 2017-10-23 | 2019-03-28 | 성균관대학교산학협력단 | Contact lens comprising ceria particles and method of fabricating the same |
KR102221923B1 (en) | 2019-09-24 | 2021-03-03 | 단국대학교 천안캠퍼스 산학협력단 | Antioxidant functional contact lens containing polyphenolic monomers and manufacturing method thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105164204A (en) | 2012-11-21 | 2015-12-16 | 路易斯维尔大学研究基金会 | Compositions and methods for reducing oxidative damage |
KR20210008664A (en) * | 2019-07-15 | 2021-01-25 | 주식회사 아이씨케이 | Anitimicrobial hydrogel contact lens comprising chitosan and polyphenol |
US11754753B2 (en) | 2020-04-27 | 2023-09-12 | Coopervision International Limited | Antioxidant contact lens |
-
2022
- 2022-02-28 KR KR1020220025754A patent/KR102600599B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006136409A (en) | 2004-11-10 | 2006-06-01 | Hoya Corp | Method for manufacturing surface-treated intraocular lens and secondary cataract inhibiting intraocular lens |
US20180292677A1 (en) | 2017-04-10 | 2018-10-11 | Benq Materials Corporation | Ophthalmic lens and method for manufacturing the same |
KR101963513B1 (en) | 2017-10-23 | 2019-03-28 | 성균관대학교산학협력단 | Contact lens comprising ceria particles and method of fabricating the same |
KR102221923B1 (en) | 2019-09-24 | 2021-03-03 | 단국대학교 천안캠퍼스 산학협력단 | Antioxidant functional contact lens containing polyphenolic monomers and manufacturing method thereof |
Also Published As
Publication number | Publication date |
---|---|
KR20230128653A (en) | 2023-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20200407324A1 (en) | Polymerizable fused tricyclic compounds as absorbers of uv and visible light | |
EP2443486B1 (en) | Biomedical devices | |
WO2007050394A2 (en) | Polymeric radiation-absorbing materials and ophthalmic devices comprising same | |
EP1949144A2 (en) | Radiation-absorbing polymeric materials and ophthalmic devices comprising same | |
TWI630931B (en) | Ophthalmic lens and manufacturing method thereof | |
EP3743270B1 (en) | Cast-molding process for producing uv-absorbing contact lenses | |
KR20160149209A (en) | (meth)acrylamid polymers for contact lens and intraocular lens | |
CN113939762B (en) | Contact lenses exhibiting improved visual properties | |
CN112334444A (en) | Polymerizable absorbers for UV and high energy visible light | |
JPH10339857A (en) | Manufacture of chemical slow controlled releasing contact lens and chemical slow controlled releasing contact lens obtained by the same | |
CN106413755B (en) | Medical instrument containing negative ionic drugs | |
EP3676082A1 (en) | Cast-molding process for producing contact lenses | |
TW201836651A (en) | Ophthalmic lens and manufacturing method thereof | |
KR102600599B1 (en) | Manufacturing method of hydrogel contact lens having reactive oxigen species scavenging ability using reactive polypehnol | |
TW201922882A (en) | Ophthalmic lens and manufacturing method thereof | |
KR20190025704A (en) | The central optic portion of the increased rigidity in the soft contact lens for astigmatic correction | |
US20230066936A1 (en) | Contact lens with improved tear film optical quality | |
EP3363862B1 (en) | Photochromic soft contact lens composition and method for preparing same | |
CN105175640B (en) | Photochromic soft contact lens compositions and methods for making same | |
KR102221923B1 (en) | Antioxidant functional contact lens containing polyphenolic monomers and manufacturing method thereof | |
KR20210008664A (en) | Anitimicrobial hydrogel contact lens comprising chitosan and polyphenol | |
EP2650021B1 (en) | Medical device for controlled release of drug | |
KR102499628B1 (en) | blue-light blocking contact lenses and manufacturing method thereof | |
CN116836145B (en) | Polymerizable photochromic compound and application thereof | |
RU2795094C2 (en) | Polymerizable condensed tricyclic compounds as uv and visible light absorbers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |